MB-108 shows activity and is well tolerated in recurrent glioblastoma, with preclinical data supporting its combination with ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible resultsSome results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback